Threats to global antimicrobial resistance control: Centrally approved and unapproved antibiotic formulations sold in India.

Sales in India of antibiotic FDCs, including unapproved formulations, are rising. In the context of increasing AMR rates nationally and globally, unapproved antibiotic FDCs undermine India's national AMR strategy and should be banned from sale.